TherapeuticsMD, Inc. — Director's Dealing 2018

Feb 13, 2018

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2017-12-31

Reporting Person: Milligan John C.K. IV (Director, President/Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-03-02	Common Stock	G	100000	—	Disposed	2690396	Indirect
2017-11-29	Common Stock	G	20000	—	Disposed	2987523	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1472419	Direct
Common Stock	1004664	Indirect

Footnotes

F1: By the Reporting Person's Grantor-Retained Annuity Trust (the "GRAT").

F2: By John C.K. Milligan Revocable Trust U/A 08/10/2009, as amended.

F3: Includes 317,127 shares of common stock previously reported as being held indirectly by the GRAT.